molnupiravir

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:molnupiravir
CAS No.:2349386-89-4
Standard:USP, BP, In-house Standards
Price(USD):Negotiable
Company:Shreeji Pharma International

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: India

    Main Sales Markets: Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Contract Manufacturing: CMO

  • Sample Provided: yes

    Payment Terms: L/C

    Molnupiravir (brand name Lagevrio) has been FDA-authorized for emergency use to treat mild-to-moderate COVID-19 since December 2021.It is used by adults 18 years of age and older who have had mild to moderate symptoms for no more than 5 days and are not hospitalized.Adverse reactions observed in the phase III MOVe-OUT study included diarrhea (2%), nausea (1%) and dizziness (1%), all of which were mild or moderate.

Send your message to this supplier
  • From:
  • To:
    Shreeji Pharma International
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service